World's Best Scientists 2026 revealed!
Thomas R. Fritsche

Thomas R. Fritsche

D-Index & Metrics

Microbiology

D-Index
72
Citations
13883
World Ranking
1796
National Ranking
763

Overview

Thomas R. Fritsche is affiliated with Marshfield Clinic in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on public health, epidemiology, molecular medicine, endocrinology, and applied microbiology and biotechnology.

The scientific work by Thomas R. Fritsche concentrates on several interrelated topics, including antibiotic resistance in bacteria, antibiotic use and resistance, bacterial identification and susceptibility testing, streptococcal infections and treatments, infective endocarditis diagnosis and management, enterobacteriaceae and cronobacter research, and neonatal and maternal infections.

Frequent coauthors collaborating with Thomas R. Fritsche include Jennifer K. Meece, Laurel Legenza, Matthew C. Hall, Brooke J. Olson, and Brooke J Olson.

The researcher has published multiple papers in notable venues such as Open Forum Infectious Diseases, Journal of Clinical Microbiology, Emerging Infectious Diseases, Scientific Reports, and the Ear Nose & Throat Journal.

Representative recent papers include:

  • Multicenter Clinical Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Using Zeus Scientific Commercial Assays, 2022, Journal of Clinical Microbiology
  • Multicenter Evaluation of the Novel ETEST Fosfomycin for Antimicrobial Susceptibility Testing of Enterobacterales, Enterococcus faecalis, and Staphylococcus Species, 2022, Journal of Clinical Microbiology
  • A geospatial approach to identify patterns of antibiotic susceptibility at a neighborhood level in Wisconsin, United States, 2023, Scientific Reports
  • Direct Tissue PCR and Genotyping for Species Identification in a Case of Laryngeal Blastomycosis, 2021, Ear Nose & Throat Journal
  • Clinical Laboratory Perspective on Streptococcus halichoeri, an Unusual Nonhemolytic, Lancefield Group B Streptococcus Causing Human Infections, 2021, Emerging Infectious Diseases

Best Publications

  • Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004)

    Gary J. Moet;Ronald N. Jones;Douglas J. Biedenbach;Matthew G. Stilwell

  • Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program

    Lalitagauri M. Deshpande;Thomas R. Fritsche;Gary J. Moet;Douglas J. Biedenbach

  • Acute Uncomplicated Cystitis in an Era of Increasing Antibiotic Resistance: A Proposed Approach to Empirical Therapy

    Thomas M. Hooton;Richard Besser;Betsy Foxman;Thomas R. Fritsche

  • Tick-borne diseases in the United States.

    Spach Dh;Liles Wc;Campbell Gl;Quick Re

  • Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).

    Jennifer M Streit;Ronald N Jones;Helio S Sader;Thomas R Fritsche

  • International Surveillance of Candida spp. and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2003)

    Shawn A. Messer;Ronald N. Jones;Thomas R. Fritsche

  • Novel bacterial endosymbionts of Acanthamoeba spp. related to the Paramecium caudatum symbiont Caedibacter caryophilus

    Matthias Horn;Thomas R. Fritsche;Romesh K. Gautom;Karl-Heinz Schleifer

  • Neochlamydia hartmannellae gen. nov., sp. nov. (Parachlamydiaceae), an endoparasite of the amoeba Hartmannella vermiformis

    Matthias Horn;Michael Wagner;Karl-Dieter Müller;Ernst N. Schmid

  • Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program (2000–2004)

    Lalitagauri M. Deshpande;Ronald N. Jones;Thomas R. Fritsche;Helio S. Sader

  • Antimicrobial Activities of Tigecycline and Other Broad-Spectrum Antimicrobials Tested against Serine Carbapenemase- and Metallo-β-Lactamase-Producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program

    Mariana Castanheira;Hélio S. Sader;Lalitagauri M. Deshpande;Thomas R. Fritsche

  • Occurrence of bacterial endosymbionts in Acanthamoeba spp. isolated from corneal and environmental specimens and contact lenses.

    T. R. Fritsche;R. K. Gautom;Seyedreza Seyedirashti;D. L. Bergeron

  • Phylogenetic diversity among geographically dispersed Chlamydiales endosymbionts recovered from clinical and environmental isolates of Acanthamoeba spp.

    Thomas R. Fritsche;Matthias Horn;Michael Wagner;Russell P. Herwig

  • In Situ Detection of Novel Bacterial Endosymbionts of Acanthamoeba spp. Phylogenetically Related to Members of the Order Rickettsiales

    Thomas R. Fritsche;Matthias Horn;Seyedreza Seyedirashti;Romesh K. Gautom

  • Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains.

    Helio S. Sader;Thomas R. Fritsche;Koné Kaniga;Yigong Ge

  • Worldwide Assessment of Dalbavancin Activity and Spectrum Against Over 6,000 Clinical Isolates

    Jennifer M Streit;Thomas R Fritsche;Helio S Sader;Ronald N Jones

  • Detection of Methyltransferases Conferring High-Level Resistance to Aminoglycosides in Enterobacteriaceae from Europe, North America, and Latin America

    Thomas R. Fritsche;Mariana Castanheira;George H. Miller;Ronald N. Jones

  • Pseudomembranous Colitis Caused by a Toxin A− B+ Strain of Clostridium difficile

    Ajit P. Limaye;David K. Turgeon;Brad T. Cookson;Thomas R. Fritsche

  • LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).

    Ronald N. Jones;Thomas R. Fritsche;Helio S. Sader;James E. Ross

  • Transmission of Histoplasma capsulatum by organ transplantation.

    A P Limaye;P A Connolly;M Sagar;T R Fritsche

  • Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003)

    T.R. Fritsche;M.G. Stilwell;R.N. Jones

Frequent Co-Authors

Ronald N. Jones
Ronald N. Jones JMI Laboratories
Helio S. Sader
Helio S. Sader JMI Laboratories
Paul R. Rhomberg
Paul R. Rhomberg University of Iowa
Ajit P. Limaye
Ajit P. Limaye University of Washington
Matthias Horn
Matthias Horn University of Vienna
Michael Wagner
Michael Wagner University of Vienna
Jennifer K. Meece
Jennifer K. Meece Marshfield Clinic
Brad T. Cookson
Brad T. Cookson University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to a variety of health and science careers. For those interested in bridging healthcare and technology, considering a best online cahiim accredited health information management degree programs can be an excellent choice. These programs prepare students for managing patient data and healthcare systems.

Career opportunities expand further with a bachelor of science in health information management salary that reflects the growing demand for experts in health data governance and compliance. Additionally, professionals can enhance their credentials through cpc certification salary pathways, which focus on accurate medical coding and billing—crucial for healthcare operations.

For those leaning towards clinical roles, becoming a functional medicine nurse practitioner offers a unique blend of traditional and integrative healthcare, with a competitive functional medicine np salary. Exploring these varied options can help microbiology graduates align their education with rewarding and in-demand careers in the healthcare sector.

Best Scientists Citing Thomas R. Fritsche

Trending Scientists